Rare diseases
Investigational molecules
Locations
Avenida Valdecilla Sn, 39008 Santander, Spain
Clinical research in Mantle Cell Lymphoma focuses on adult patients with indolent disease and treatment-naïve presentations, with interest in immunotherapy and BTK inhibitor-based combinations. The sponsor also supports studies in clinically indolent forms where rituximab is paired with targeted agents to address frontline treatment needs.
These trials reflect a strong therapeutic interest in non-chemotherapy approaches for MCL across multicenter settings.
Fundacion Geltamo runs clinical trials in conditions such as Mantle cell lymphoma, B-cell lymphoma recurrent, Hodgkin's disease, among others.
Clinical trials run by this sponsor – those enrolling participants first.
PortugalSpainSpain
AustriaSpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
